Physicochemical properties of gadoteridol and other magnetic resonance contrast agents.
Tweedle
M F
MF
Bristol-Myers Squibb Pharmaceutical Research Institute, New Brunswick, NJ 08903-0191.
D000818:Animals; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003287:Contrast Media / Q000737:chemistry* / Q000493:pharmacokinetics; D004355:Drug Stability; D005682:Gadolinium / Q000737:chemistry* / Q000493:pharmacokinetics; D006571:Heterocyclic Compounds / Q000737:chemistry* / Q000493:pharmacokinetics; D008279:Magnetic Resonance Imaging; D051379:Mice; D009942:Organometallic Compounds / Q000737:chemistry* / Q000493:pharmacokinetics; D012996:Solutions; D013329:Structure-Activity Relationship; D013997:Time Factors
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; D012996:Solutions; C062402:gadoteridol; D005682:Gadolinium